Plain-English translation of NCT07027124 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether a combination of three medications—hormone therapy, , and —can help men with high-risk prostate cancer have better outcomes. The trial gives these medications before surgery to remove the prostate, then continues with afterward. The goal is to reduce the amount of cancer that remains in the body after treatment.
High-risk prostate cancer is aggressive and can come back even after surgery. This trial is exploring whether using multiple medications together before surgery can be more effective than standard treatment alone at controlling the disease.
You likely qualify if…
You likely don't qualify if…
You would receive three medications together for about five months before having surgery to remove your prostate. After surgery heals, you would continue receiving one of the medications () for about 12 more weeks. Throughout the trial, you would have regular doctor visits, blood tests, and scans to monitor how the treatment is working and check for side effects.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States